Lewis T. "rusty" Williams - 11 May 2021 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NGNE)

Reporting relationship: Director
Issuer ticker: NGNE
Reported as of: 11 May 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 May 2021, 17:39:26 UTC
Next SEC filing: 28 May 2021
Source filing: View source filing
Reporting owner signature: /s/ Kris McGrew, Attorney-in-Fact for Lewis T. Williams

Key filing fact

Lewis T. "rusty" Williams filed Form 4 for Neoleukin Therapeutics, Inc. (NGNE) on 13 May 2021.

Key facts

This page summarizes Lewis T. "rusty" Williams's Form 4 filing for Neoleukin Therapeutics, Inc. (NGNE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 May 2021, 17:39.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NLTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +25,000
Change %
Price: $0.000000
Shares after: 25,000
Date: 11 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price: $11.40
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests as to 1/12 of the total shares monthly beginning June 11, 2021 until the option is fully vested on May 11, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date.